Total Visits
| Views | |
|---|---|
| Intracranial ... | 64 |
Total Visits Per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Intracranial ... | 0 | 0 | 0 | 1 | 1 | 3 | 2 |
File Visits
| Views | |
|---|---|
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021.pdf | 24 |
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula5.pdf | 14 |
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula2.pdf | 13 |
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula3.pdf | 13 |
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula1.pdf | 12 |
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_figura1.pdf | 11 |
| intracranial_and_extracranial_efficacy_lorlatinib_patients_alk_positive_non_small_cell_lung_cancer_previously_treated_second_generation_alk_tkis_2021_taula4.pdf | 9 |
Top country views
| Views | |
|---|---|
| United States | 40 |
| Spain | 10 |
| Canada | 6 |
| Germany | 2 |
| United Kingdom | 2 |
| Belgium | 1 |
| Cyprus | 1 |
| Finland | 1 |
| France | 1 |
Top cities views
| Views | |
|---|---|
| Chandler | 11 |
| Barcelona | 7 |
| Ashburn | 5 |
| Chicago | 5 |
| Québec | 3 |
| Beauharnois | 2 |
| London | 2 |
| Boardman | 1 |
| Brussels | 1 |
| Des Moines | 1 |